oseltamivir has been researched along with Genetic Predisposition in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Rezaei, N; Yousefzadegan, S | 1 |
Choy, KL; Chung, JP; Ho, LN | 1 |
Barr, IG; Caldwell, N; Cui, L; Deng, YM; Freeman, K; Hurt, AC; Kelso, A; Komadina, N; Leang, SK; Lee, RT; Lin, RT; Maurer-Stroh, S; Phuah, SP; Smith, D; Speers, D | 1 |
3 other study(ies) available for oseltamivir and Genetic Predisposition
Article | Year |
---|---|
Case Report: Death due to COVID-19 in Three Brothers.
Topics: Aged; Betacoronavirus; Coronavirus Infections; COVID-19; Fatal Outcome; Genetic Predisposition to Disease; Humans; Hydroxychloroquine; Iran; Lung; Male; Middle Aged; Oseltamivir; Pandemics; Pneumonia, Viral; SARS-CoV-2; Siblings; Tomography, X-Ray Computed | 2020 |
Oseltamivir-induced mania in a patient with H1N1.
Topics: Adolescent; Antiviral Agents; Bipolar Disorder; Female; Genetic Predisposition to Disease; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Oseltamivir | 2010 |
Increased detection in Australia and Singapore of a novel influenza A(H1N1)2009 variant with reduced oseltamivir and zanamivir sensitivity due to a S247N neuraminidase mutation.
Topics: Antiviral Agents; Australia; Drug Resistance; Genetic Predisposition to Disease; Genetic Variation; Humans; Incidence; Influenza A Virus, H1N1 Subtype; Influenza, Human; Neuraminidase; Oseltamivir; Polymorphism, Single Nucleotide; Population Surveillance; Risk Assessment; Risk Factors; Singapore; Zanamivir | 2011 |